정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2277 | Terminated | A Trial of Remdesivir in Adults With Severe COVID-19 | SARS-CoV-2 | Drug: Remdesivir Drug: Remdesivir placebo |
Phase 3 | Capital Medical University | OTHER | 237 | All | 18 Years | Bin Cao, Beijing, Beijing, China |
| 2276 | Recruiting | A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy | Multiple Myeloma | Biological: mRNA-1273 | Phase 2 | National Cancer Institute (NCI) | NIH | 120 | All | 18 Years | National Institutes of Health Clinical Center, Bethesda, Maryland, United States |
| 2275 | Terminated | A Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVID-19) | COVID-19 | Drug: Rivaroxaban Drug: Placebo |
Phase 2 | Bill & Melinda Gates Medical Research Institute | OTHER | 497 | All | 18 Years | Woodland Research Northwest LLC - ERG - PPDS, Rogers, Arkansas, United States Science 37, Inc, Los Angeles, California, United States Allergy and Asthma Medical Group and Research Center - CRN - PPDS, San Diego, California, United States Invesclinic, LLC, Fort Lauderdale, Florida, United States Advanced Pulmonary Research Institute, Loxahatchee Groves, Florida, United States LCC Medical Research - Miami - BTC - PPDS, Miami, Florida, United States Adult Medicine of Lake County, Mount Dora, Florida, United States Providea Health Partners LLC, Evergreen Park, Illinois, United States Clinical Research Institute, Inc - CRN - PPDS, Minneapolis, Minnesota, United States Encompass Care, North Las Vegas, Nevada, United States Riverside Medical Group - Circuit- PPDS, Secaucus, New Jersey, United States NYC Health + Hospitals/Lincoln, Bronx, New York, United States Elmhurst Hospital Center, Elmhurst, New York, United States Harlem Hospital Center, New York, New York, United States Premier Family Physicians - Austin - Hunt - PPDS, Austin, Texas, United States Village Health Partners - Plano - Hunt - PPDS, Plano, Texas, United States South Texas Allergy and Asthma Medical Professionals, San Antonio, Texas, United States Boundary House Medical Centre, Sale, Cheshire, United Kingdom St Mary's Hospital - PPDS, London, City Of London, United Kingdom Royal Free Hospital, London, United Kingdom |
| 2274 | Recruiting | A Trial to Investigate Recovery From COVID-19 With C21 in Adult Subjects | Covid19 | Drug: C21 Drug: Placebo |
Phase 3 | Vicore Pharma AB | INDUSTRY | 600 | All | 18 Years | University of California Irvine Medical Center, Orange, California, United States Northwestern Medicine Central DuPage Hospital, Winfield, Illinois, United States Parkview Physicians Group - Infectious Diseases, Fort Wayne, Indiana, United States Johns Hopkins, Baltimore, Maryland, United States Trinity Health, Minot, North Dakota, United States Lehigh Valley Hospital - 17th Street, Allentown, Pennsylvania, United States Lowcountry Infectious Diseases, Charleston, South Carolina, United States Houston Methodist Hospital, Houston, Texas, United States Carilion Roanoke Memorial Hospital, Roanoke, Virginia, United States Instituto Medico Rio Cuarto, Rio Cuarto, Cordoba, Argentina Hospital Italiano Rosario - Centro, Rosario, Santa Fe, Argentina Hospital Italiano Rosario, Rosario, Santa Fe, Argentina Nuevo Hospital San Roque, Cordoba, Argentina Hospital das Clinicas da Faculdade de Medicina de Botucatu, Botucatu, Brazil Hospital Brasilia, Brasilia, Brazil Fundacao Universidade de Caxias do Sul, Caxias Do Sul, Brazil Centro de Pesquisas Clinicas de Natal, Natal, Brazil Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil Hospital Alemao Oswaldo Cruz - Paulista, Sao Paulo, Brazil Clinica Somer, Medellin, Antioquia, Colombia Fundacion Santa Fe de Bogota, Bogota, Cundinamarca, Colombia Hospital Universitario San Ignacio, Bogota, Cundinamarca, Colombia Fakultni Nemocnice u sv. Anny v Brn?, Brno, Czechia Fakultni Nemocnice u sv. Anny v Brn?, Brno, Czechia Nemocnice Slany, Slany, Czechia Masarykova nemocnice v Usti nad Labem, Usti Nad Labem, Czechia Hospital Nacional Carlos Alberto Seguin Escobedo, Arequipa, Peru Hospital Nacional Arzobispo Loayza, Lima Cercado, Peru Clinic International - Headquarters Lima, Lima Cercado, Peru Southern Philippines Medical Center, Davao City, Philippines West Visayas State University Medical Center, Iloilo City, Philippines Makati Medical Center, Makati, Philippines The Medical City, Pasig, Philippines Lung Center of the Philippines, Quezon City, Philippines Quirino Memorial Medical Center, Quezon City, Philippines St. Luke's Medical Center - Global City, Taguig, Philippines City Clinical Hospital №4" of the Dnipro City Council, Dnipro, Ukraine City Clinical Hospital №13" Of Kharkiv City Council, Kharkiv, Ukraine Regional Clinical Hospital of Infectious Diseases, Kharkiv, Ukraine Oleksandrivska Kyiv City Clinical Hospital, Kyiv, Ukraine Vinnytsia City Clinical Hospital №1, Vinnytsia, Ukraine Hospital №1 of Zhytomyr City Council, Zhytomyr, Ukraine |
| 2273 | Not yet recruiting | A Trial Using ANAKINRA, TOCILIZUMAB Alone or in Association With RUXOLITINIB in Severe Stage 2b and 3 of COVID19-associated Disease | Covid19 | Drug: Anakinra +/- Ruxolitinib (stages 2b/3) Drug: Anakinra and Ruxolitinib (Advanced stage 3) Drug: Tocilizumab +/- ruxolitinib (stages 2b/3) Drug: Tocilizumab and Ruxolitinib (Advanced stage 3) Other: Standard of care |
Phase 3 | Assistance Publique Hopitaux De Marseille | OTHER | 216 | All | 18 Years ~ 75 Years | Assistance Publique Hopitaux de Marseille, Marseille, France |
| 2272 | Terminated | A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19 | Covid19 | Drug: Nitazoxanide Drug: Placebo Nitazoxanide Drug: Ribavirin Drug: Placebo Ribavirin Drug: Hydroxychloroquine Drug: Placebo Hydroxychloroquine |
Phase 2 | Rutgers, The State University of New Jersey, SynaVir | OTHER | 7 | All | 21 Years | Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States |
| 2271 | Withdrawn | Abatacept for Patients With COVID-19 and Respiratory Distress | COVID-19 | Drug: Abatacept | Phase 2 | Beth Israel Deaconess Medical Center, Boston Children's Hospital, Bristol-Myers Squibb, Brigham and Women's Hospital | OTHER | 0 | All | 18 Years | Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States Boston Children's Hospital, Boston, Massachusetts, United States |
